Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by Kevelleon Jan 30, 2018 12:02am
244 Views
Post# 27459996

@ longonMJ... agree with you on CBW

@ longonMJ... agree with you on CBW

Under the terms of the agreement, Cannabis Wheaton will invest $12 million for the initial costs for the Phase I construction of the 100,000 square feet of the IDP Facility. In return, Cannabis Wheaton will receive a minority equity interest in CannabisCo and a perpetual stream of 30% of all cannabis or cannabis-derived products, including any cannabis trim produced at the facility.

Upon successful initial implementation of the Cultivation Technology, the facility is expected to yield up to 200,000 square feet of effective cultivation space. The Company estimates that its cannabis stream from Phase I of the facility will result in ~7.5 million grams of cannabis per annum. The agreement also has an option to fund an additional two 100,000 square foot expansion of the Facility, which can increase the overall Facility cultivation footprint to 300,000 square feet. The Expansion Phases are subject to the satisfactory due diligence and the parties mutually agreeing to a construction budget and timeline

IDP is planning to operate out of the Nestle Canada plant in Chesterville, Ontario, which covers 60 acres of land and hosts an existing 373,000 square feet of building space. The facility provides a location advantage to access railway and highway networks. The transaction remains subject to certain conditions precedent including receipt of applicable regulatory approvals and the execution of a definitive agreement, which the parties expect to occur within 60 days.

Cannabis Wheaton believes IDP’s proprietary vertical cultivation system and custom-made fabricated LED lighting systems can set new standards for yields per square foot and operating cash costs per gram for indoor cultivation.

Cannabis Wheaton, the world’s first cannabis streaming company, announced Wednesday that it has inked an interim supply agreement with Aphria Inc. (TSX:APH). As per the agreement, Aphria will supply Wheaton’s subsidiary Navisent Inc., created for establishing international distribution channels, with up to 60,000 kgs of cannabis, including dried flower and cannabis oil through February 1, 2022. The supply agreement enables Cannabis Wheaton to accelerate the execution of its international distribution strategy 12-18 months ahead of schedule. A definite agreement that will supersede this interim agreement will be entered into between both companies shortly.

For CBD non THC investors, see Isodiol.  
For vertical integration farming, see FFT. 
For undervalued potential, see True Leaf Medicine

Bullboard Posts